Brexit Medicine plc is considering buying some equipment to produce a medical drug named SHN. The new equipment's capital cost is estimated at £100 million. If its purchase is approved now, the drug can be bought and production can commence by the end of the year. £50 million has already been spent on research and development work. Estimates of revenues and costs arising from the operation of the drug are: Year 1 Year 2 Year 3 100 0.8 Year 4 Year 5 80 Sales price (£/litre) Sales volume (million litres) Variable cost (£/litre) Fixed cost (£m) 120 120 100 1 1.2 1 0.8 50 30 50 30 40 30 40 30 30 30 If the equipment is bought, sales of some existing products will be lost resulting in a loss of contribution of £15 million a year, over the life of the equipment. The accountant has informed you that the fixed cost includes depreciation of £20 million a year on the new equipment. It also includes an allocation of £10 million for fixed overheads. A separate study has indicated that if the new equipment were bought, additional overheads, excluding depreciation, arising from producing the drug would be £8 million a year. Production would require additional working capital of £30 million immediately, and from Year 2, this will increase each year by a further £5 million. For the purposes of your initial calculations, ignore taxation. Required: a. Calculate the relevant annual cash flows associated with buying the equipment.
Brexit Medicine plc is considering buying some equipment to produce a medical drug named SHN. The new equipment's capital cost is estimated at £100 million. If its purchase is approved now, the drug can be bought and production can commence by the end of the year. £50 million has already been spent on research and development work. Estimates of revenues and costs arising from the operation of the drug are: Year 1 Year 2 Year 3 100 0.8 Year 4 Year 5 80 Sales price (£/litre) Sales volume (million litres) Variable cost (£/litre) Fixed cost (£m) 120 120 100 1 1.2 1 0.8 50 30 50 30 40 30 40 30 30 30 If the equipment is bought, sales of some existing products will be lost resulting in a loss of contribution of £15 million a year, over the life of the equipment. The accountant has informed you that the fixed cost includes depreciation of £20 million a year on the new equipment. It also includes an allocation of £10 million for fixed overheads. A separate study has indicated that if the new equipment were bought, additional overheads, excluding depreciation, arising from producing the drug would be £8 million a year. Production would require additional working capital of £30 million immediately, and from Year 2, this will increase each year by a further £5 million. For the purposes of your initial calculations, ignore taxation. Required: a. Calculate the relevant annual cash flows associated with buying the equipment.
Chapter1: Financial Statements And Business Decisions
Section: Chapter Questions
Problem 1Q
Related questions
Question
Expert Solution
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
Step by step
Solved in 3 steps
Knowledge Booster
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, accounting and related others by exploring similar questions and additional content below.Recommended textbooks for you
Accounting
Accounting
ISBN:
9781337272094
Author:
WARREN, Carl S., Reeve, James M., Duchac, Jonathan E.
Publisher:
Cengage Learning,
Accounting Information Systems
Accounting
ISBN:
9781337619202
Author:
Hall, James A.
Publisher:
Cengage Learning,
Accounting
Accounting
ISBN:
9781337272094
Author:
WARREN, Carl S., Reeve, James M., Duchac, Jonathan E.
Publisher:
Cengage Learning,
Accounting Information Systems
Accounting
ISBN:
9781337619202
Author:
Hall, James A.
Publisher:
Cengage Learning,
Horngren's Cost Accounting: A Managerial Emphasis…
Accounting
ISBN:
9780134475585
Author:
Srikant M. Datar, Madhav V. Rajan
Publisher:
PEARSON
Intermediate Accounting
Accounting
ISBN:
9781259722660
Author:
J. David Spiceland, Mark W. Nelson, Wayne M Thomas
Publisher:
McGraw-Hill Education
Financial and Managerial Accounting
Accounting
ISBN:
9781259726705
Author:
John J Wild, Ken W. Shaw, Barbara Chiappetta Fundamental Accounting Principles
Publisher:
McGraw-Hill Education